胃癌化疗在日本的现状演示幻灯片.pptVIP

Dr Macdonald reported Inter-group study showed post operative chemo-radiation prolonged OS and DS after limited surgery (D0/D1). Moreover, Dr Cunningham reported peri-operative chemotherapy prolonged survival in MAGIC trial. There is no doubt to agree with the data of these study. But, D2 is a standard surgeryt in Japan. We should establish our standard treatment in the adjuvant setting. Japan clinical oncology group conducted a couple of trials and TAIHO did N-SAS-GC trial. Let me introduce these trials. S-1+CDDP was superior to S-1 in SPRITS in Japan. Now FLAGS trial is on-going in red co